CompoAtlas

Joint Support

Joint Support, licence 80067385: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Nutragenius Inc.
NPN or DIN-HM
80067385
Status
Inactive licence
Licence date
3 March 2016
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
3,3',4',5,7-Pentahydroxyflavone

Source : Fruit

150.0 mgNot calculated
Sulfate de 2-amino-2-désoxy-D-glucose

Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crevettes

375.0 mgNot calculated
Vaccinium angustifolium

Source : Fruit

Extraction ratio : 40:1

Dry plant equivalent : 400 mg

10.0 mgNot calculated
Vitamine C

Source : Acide ascorbique

20.0 mg80,000 µg
Vitis vinifera L.

Source : Graine(s)

Potency : 85.0 % Oligomeric proanthocyanidins

20.0 mgNot calculated
Ginkgo biloba

Source : Feuille

Extraction ratio : 50:1

Dry plant equivalent : 1.5 g

Potency : 24.0 % Flavone glycosides

30.0 mgNot calculated
Ginkgo biloba

Source : Feuille

Potency : 6.0 % Trepene lactones

Not specifiedNot calculated
Sulfate de chondroïtine

Source : Chondroitin sulfate sodium obtained from avian cartilage

30.0 mgNot calculated
Méthylsulfonylméthane10.0 mgNot calculated
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Source : bactéries, levures

15.0 mgNot calculated

Non-medicinal ingredients

Hypromellose, Chlorophylle

PopulationAgeQuantity per servingFrequency
AdultesNot specified2.0 Capsule2.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. Helps in the development and maintenance of bones. Helps in the development and maintenance of cartilage. Helps in connective tissue formation. Helps in wound healing. Source of antioxidants for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80067385

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line